L. R. SUTHERLAND, M.D.; L. A. EDWARDS, M.D., F.R.C.P.(C); A. MEDLINE, M.D., F.R.C.P.(C); R. W. WILKINSON, M.D., F.R.C.S.(C); J. J. CONNON, M.D., M.R.C.P.(Lond), F.R.C.P.(C)
Two cases of meglumine iodipamide (Cholografin®) hepatotoxicity were confirmed by liver biopsy. The hepatic lesion was centrilobular in location and resolved within a short period of time. Nausea and vomiting commonly reported after intravenous cholangiography may be clinical manifestations of this entity.
Learn more about subscription options.
Register Now for a free account.
SUTHERLAND LR, EDWARDS LA, MEDLINE A, WILKINSON RW, CONNON JJ. Meglumine lodipamide (Cholografin®) Hepatotoxicity. Ann Intern Med. 1977;86:437-439. doi: 10.7326/0003-4819-86-4-437
Download citation file:
Published: Ann Intern Med. 1977;86(4):437-439.
Emergency Medicine, Gastroenterology/Hepatology, Liver Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only